Unknown

Dataset Information

0

Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.


ABSTRACT:

Background

Large-scale collaborative precision medicine initiatives (e.g., The Cancer Genome Atlas (TCGA)) are yielding rich multi-omics data. Integrative analyses of the resulting multi-omics data, such as somatic mutation, copy number alteration (CNA), DNA methylation, miRNA, gene expression, and protein expression, offer tantalizing possibilities for realizing the promise and potential of precision medicine in cancer prevention, diagnosis, and treatment by substantially improving our understanding of underlying mechanisms as well as the discovery of novel biomarkers for different types of cancers. However, such analyses present a number of challenges, including heterogeneity, and high-dimensionality of omics data.

Methods

We propose a novel framework for multi-omics data integration using multi-view feature selection. We introduce a novel multi-view feature selection algorithm, MRMR-mv, an adaptation of the well-known Min-Redundancy and Maximum-Relevance (MRMR) single-view feature selection algorithm to the multi-view setting.

Results

We report results of experiments using an ovarian cancer multi-omics dataset derived from the TCGA database on the task of predicting ovarian cancer survival. Our results suggest that multi-view models outperform both view-specific models (i.e., models trained and tested using a single type of omics data) and models based on two baseline data fusion methods.

Conclusions

Our results demonstrate the potential of multi-view feature selection in integrative analyses and predictive modeling from multi-omics data.

SUBMITTER: El-Manzalawy Y 

PROVIDER: S-EPMC6157248 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.

El-Manzalawy Yasser Y   Hsieh Tsung-Yu TY   Shivakumar Manu M   Kim Dokyoon D   Honavar Vasant V  

BMC medical genomics 20180914 Suppl 3


<h4>Background</h4>Large-scale collaborative precision medicine initiatives (e.g., The Cancer Genome Atlas (TCGA)) are yielding rich multi-omics data. Integrative analyses of the resulting multi-omics data, such as somatic mutation, copy number alteration (CNA), DNA methylation, miRNA, gene expression, and protein expression, offer tantalizing possibilities for realizing the promise and potential of precision medicine in cancer prevention, diagnosis, and treatment by substantially improving our  ...[more]

Similar Datasets

| S-EPMC10869561 | biostudies-literature
| S-EPMC5870540 | biostudies-literature
| S-EPMC5209828 | biostudies-literature
| S-EPMC4029432 | biostudies-literature
| S-EPMC7423957 | biostudies-literature
| S-EPMC9122960 | biostudies-literature
| S-EPMC6656333 | biostudies-literature
| S-EPMC9533501 | biostudies-literature
| S-EPMC1569877 | biostudies-literature
| S-EPMC6712585 | biostudies-literature